Issue navigation
Volume 23, Issue 12, 1 December 2017
Editors' Commentary
Improving the Reproducibility and Quality of Reporting for Animal Studies in Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2069–2071, https://doi.org/10.1097/MIB.0000000000001283
Future Directions and Methods for IBD Research
Findings of Retrograde Contrast Study Through Double-balloon Enteroscopy Predict the Risk of Bowel Resections in Patients with Crohn's Disease with Small Bowel Stenosis
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2097–2103, https://doi.org/10.1097/MIB.0000000000001175
Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2104–2108, https://doi.org/10.1097/MIB.0000000000001259
IBD LIVE
Dietary Polyphenols in the Aetiology of Crohn's Disease and Ulcerative Colitis—A Multicenter European Prospective Cohort Study (EPIC)
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2072–2082, https://doi.org/10.1097/MIB.0000000000001108
Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2083–2088, https://doi.org/10.1097/MIB.0000000000001258
Indirect Costs and Family Burden of Pediatric Crohn's Disease in the United States
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2089–2096, https://doi.org/10.1097/MIB.0000000000001268
Original Article
Targeted Gene Panel Sequencing for Early-onset Inflammatory Bowel Disease and Chronic Diarrhea
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2109–2120, https://doi.org/10.1097/MIB.0000000000001235
Obese Patients Undergoing Ileal Pouch–Anal Anastomosis: Short-and Long-term Surgical Outcomes
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2142–2146, https://doi.org/10.1097/MIB.0000000000001238
Serum Hepcidin in Children with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2165–2171, https://doi.org/10.1097/MIB.0000000000001245
Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2197–2201, https://doi.org/10.1097/MIB.0000000000001248
Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2209–2214, https://doi.org/10.1097/MIB.0000000000001249
Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2180–2188, https://doi.org/10.1097/MIB.0000000000001251
Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2134–2141, https://doi.org/10.1097/MIB.0000000000001252
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2202–2208, https://doi.org/10.1097/MIB.0000000000001255
Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the Long-term Outcome of Patients with Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2172–2179, https://doi.org/10.1097/MIB.0000000000001260
Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2227–2237, https://doi.org/10.1097/MIB.0000000000001262
Impact of Prostate Cancer and Its Treatment on the Outcomes of Ileal Pouch-Anal Anastomosis
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2147–2153, https://doi.org/10.1097/MIB.0000000000001263
Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2189–2196, https://doi.org/10.1097/MIB.0000000000001267
Phenotype and Management of Infantile-onset Inflammatory Bowel Disease: Experience from a Tertiary Care Center in China
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2154–2164, https://doi.org/10.1097/MIB.0000000000001269
Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2238–2244, https://doi.org/10.1097/MIB.0000000000001275
Real-world Experience of Anti–tumor Necrosis Factor Therapy for Internal Fistulas in Crohn's Disease: A Retrospective Multicenter Cohort Study
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2245–2251, https://doi.org/10.1097/MIB.0000000000001276
Bone Mass Development from Childhood into Young Adulthood in Patients with Childhood-onset Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2215–2226, https://doi.org/10.1097/MIB.0000000000001277
Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2252–2255, https://doi.org/10.1097/MIB.0000000000001280
Accumulation of HLA-DR4 in Colonic Epithelial Cells Causes Severe Colitis in Homozygous HLA-DR4 Transgenic Mice
Inflammatory Bowel Diseases, Volume 23, Issue 12, 1 December 2017, Pages 2121–2133, https://doi.org/10.1097/MIB.0000000000001282
